Tengfei Creation Center,55 Jiangjun Avenue, Jiangning District,Nanjing admin@sinochem-nanjing.com 3389378665@qq.com
Follow us:

Drostanolone Propionate

    • Product Name Drostanolone Propionate
    • Alias Masteron
    • Einecs 200-368-4
    • Mininmum Order 1 g
    • Factory Site Tengfei Creation Center,55 Jiangjun Avenue, Jiangning District,Nanjing
    • Price Inquiry admin@sinochem-nanjing.com
    • Manufacturer Sinochem Nanjing Corporation
    • CONTACT NOW
    VTB
    Specifications

    HS Code

    606594

    Chemical Name Drostanolone Propionate
    Common Name Masteron
    Molecular Formula C23H36O3
    Molecular Weight 360.53 g/mol
    Drug Class Anabolic androgenic steroid
    Route Of Administration Intramuscular injection
    Half Life 2-3 days
    Primary Use Treatment of breast cancer and performance enhancement
    Appearance White crystalline powder
    Legal Status Controlled substance in many countries
    Melting Point 125-126°C
    Development Year 1959
    Brand Names Masteril, Drolban, Metormon

    As an accredited Drostanolone Propionate factory, we enforce strict quality protocols—every batch undergoes rigorous testing to ensure consistent efficacy and safety standards.

    Packing & Storage
    Packing The Drostanolone Propionate packaging features a sealed 10ml vial, labeled with dosage, batch number, expiration date, and manufacturer’s details.
    Shipping Drostanolone Propionate is shipped in secure, leak-proof containers, complying with all relevant chemical and safety regulations. Packages are clearly labeled and protected against moisture, light, and temperature extremes. Shipping includes documentation for safe handling, and tracking is provided. Only authorized and compliant recipients are eligible for delivery due to its controlled status.
    Storage Drostanolone Propionate should be stored in a tightly sealed container at controlled room temperature, typically between 20°C to 25°C (68°F to 77°F), away from direct light, moisture, and heat sources. Keep it in a secure location, away from incompatible substances, and out of reach of unauthorized individuals, children, and animals. Proper storage ensures stability and maintains its chemical integrity.
    Application of Drostanolone Propionate

    Applications of Drostanolone Propionate in Industrial Manufacturing

    Drostanolone Propionate serves as a specialized chemical raw material in regulated pharmaceutical synthesis and closely associated biotechnological production environments. Downstream manufacturers integrate this compound for its androgenic-anabolic characteristics, strict regulatory requirements, and targeted roles in advanced formulation areas. Below, we detail primary industrial application sectors and critical process considerations.

    1. Pharmaceutical Injectable Preparation for Hormonal Therapeutics

    Pharmaceutical manufacturers rely on this material as an active pharmaceutical ingredient (API) for the production of androgenic hormonal injectables used in clinical and hospital settings. Factory operations require rigorous GMP controls during weighing, dissolution, sterile filtration, and aseptic filling. Material input is batch-specific, with validation-driven quantification for each injectable formulation per regulatory monograph. The production process includes comprehensive in-process quality controls, residual solvent monitoring, and frequent analytical testing for micronization consistency. End-products primarily target specialist clinics under hospital prescription protocols.

    Industry compliance standards

    • EU GMP Part II: Basic Requirements for APIs
    • United States Pharmacopeia (USP) Monograph for Drostanolone Propionate
    • ICH Q7: Good Manufacturing Practice Guidance for Active Pharmaceutical Ingredients
    • Chinese Pharmacopoeia, Injectable Raw Material Requirements

    Typical usage ratio

    • Preparation input varies by finished dose, typically measuring 50–100 mg per finished 1 mL ampoule or cartridge.
    • Adjustment based on the target therapy protocol and market-specific registration dossier.

    Downstream process integration

    • API dissolved in pharmaceutical-grade carrier oils (e.g., benzyl benzoate/ethyl oleate) during pre-formulation.
    • Entry point: post-synthetic QC batch release, pre-mixing phase prior to sterile filtration.
    • Integration with nitrogen blanketing/low-shear agitation in validated cleanroom environments.
    • Subjected to UPLC/HPLC content uniformity and sterility testing before filling.

    Final product types

    • Ready-to-use injectable androgenic hormone ampoules
    • Multi-dose vials for clinical therapeutics
    • Glass cartridge-based injectables for hospital use
    • Pre-filled sterile syringes distributed to licensed pharmacies

    2. Clinical Reference Standard Manufacturing

    Chemical and life science laboratories use highly purified batches as certified reference standards for in vitro assay validation and analytical calibration. Material undergoes specialized purification, followed by characterization via HPLC, MS, and NMR to meet traceable certification criteria. Reference standard kits produced under ISO/IEC 17025 requirements facilitate analytical accuracy in clinical monitoring of steroid panels. Typically, the laboratories employing these standards operate in hospital, toxicology testing, or public health agency networks where consistency in analytical batch certification is mandatory.

    Industry compliance standards

    • ISO/IEC 17025: General requirements for testing and calibration laboratories
    • USP Reference Standards Program Guidelines
    • FDA Current Good Manufacturing Practice (cGMP) for Laboratory Controls (21 CFR 211)
    • WHO Laboratory Quality Management System (LQMS)

    Typical usage ratio

    • Supplied as 10–50 mg vials for laboratory calibration assays
    • Concentration and mass tailored to detection method: LC-MS, GC-MS, or immunoassay

    Downstream process integration

    • Batches undergo multi-step recrystallization and HPLC fractionation to eliminate batch impurities
    • Packing phase: single-use vials or ampoules under argon atmosphere for extended stability
    • Certification includes full chromatographic and spectral fingerprinting per lot
    • Cross-referenced with global pharmacopoeial methods

    Final product types

    • Clinical Certified Reference Materials (CRM)
    • In vitro diagnostic kit standards
    • Analytical assay calibration vials
    • Secondary laboratory reference solutions for international research projects

    3. Pharmacological Preclinical Research Compounds

    Research institutes and contract research organizations procure this compound to support preclinical models examining androgenic pathway activity and metabolic clearance. Regulatory-compliant manufacturers supply small, highly characterized lots for direct use by biomedical scientists in both in vivo animal testing and in vitro receptor binding studies. The production process includes micro-batch synthesis, rigorous documentation, and containment protocols for handling controlled substances. Material is provided in research-grade packaging with traceable certificate of analysis (COA) for each lot, fulfilling both ethical board requirements and international material transfer regulations.

    Industry compliance standards

    • OECD Principles of Good Laboratory Practice (GLP)
    • EU Directive 2010/63/EU on animal use in scientific research
    • US NIH Guidelines for Chemical Handling in Research
    • Material transfer agreements for controlled substances

    Typical usage ratio

    • Small-scale studies: 1–10 mg per animal model or per 96-well assay plate, as defined by study protocol
    • Adjustment for body weight, receptor sensitivity, and mechanism-of-action endpoints

    Downstream process integration

    • Aliquoting under clean-cabinet conditions to single-use vials
    • Timed delivery to research labs with chain-of-custody documentation
    • COA and safety data sheet (SDS) accompany all shipments
    • Material introduced during compound dosing or primary bioassay preparation phases

    Final product types

    • Preclinical animal testing kits
    • Receptor-binding assay solutions
    • In vitro metabolism research standards
    • Bioanalytical positive controls for research labs

    4. Pharmaceutical Impurity Profiling and Identification

    Pharmaceutical QC laboratories employ specialized batches as reference impurities during drug substance and finished product analysis. Manufacturers supply lower-purity fractions retained from main API production, annotated with impurity spectra and specific degradation pathway profiles. Laboratories apply these profiles to meet regulatory filing demands for impurity detection, stability studies, and shelf-life determination under ICH Q3A/Q3B guidance. The supplied impurity standards allow downstream users to validate identification methods for related compounds and ensure compliance with stringent international pharmacopoeial impurity thresholds.

    Industry compliance standards

    • ICH Q3A(R2)/Q3B(R2): Impurities in New Drug Substances
    • USP General Chapter <621> Chromatography
    • European Pharmacopoeia (Ph. Eur.) Monograph for related substances
    • FDA Drug Substance Impurity Guidelines

    Typical usage ratio

    • Supplied at 0.5–2.0 mg/mL standard solutions, concentrations matched to analytical method requirements
    • Calibration levels based on known process impurity profiles of main API production

    Downstream process integration

    • Analytical spike-in to HPLC/UPLC or GC runs during QC batch release
    • Documentation included: full impurity profile, origin, and stability data
    • Used for method development, validation, and routine stability-indicating studies
    • Applied during shelf-life extension and out-of-spec investigations

    Final product types

    • Primary impurity reference standards kits
    • Method validation sample panels
    • Stability investigation assay materials
    • Regulatory submission impurity documentation reference vials
    Free Quote

    Competitive Drostanolone Propionate prices that fit your budget—flexible terms and customized quotes for every order.

    For samples, pricing, or more information, please call us at +8615371019725 or mail to admin@sinochem-nanjing.com.

    We will respond to you as soon as possible.

    Tel: +8615371019725

    Email: admin@sinochem-nanjing.com

    Get Free Quote of Sinochem Nanjing Corporation

    Flexible payment, competitive price, premium service - Inquire now!

    Certification & Compliance
    More Introduction

    Drostanolone Propionate: A Manufacturer’s Perspective

    Introduction to Drostanolone Propionate

    Here on the production floor, genuine work goes into every batch of Drostanolone Propionate. It’s a chemical we’ve come to know inside and out after years of manufacturing. Whether you come from pharmaceutical development, sports medicine, or analytical research, understanding the details separates workable solutions from wishful thinking. Our experience isn’t from reading product sheets — it’s from running the reactors, controlling the crystallization, and watching the raw material move through each step until we see those fine white crystals. Each lot carries with it rigorous scrutiny, not only because regulations demand it, but because our reputation and the health of end-users hang in the balance.

    Drostanolone Propionate has a model history in androgen and anabolic compound production. You’re not looking at an anonymous white powder. You’re looking at a molecule that’s drawn serious attention both in clinics and research. What gives this product its edge goes back to structure: Drostanolone uses the propionate ester. That’s where the “propionate” part matters — compared with longer esters or unmodified forms, this variant allows careful control over the compound’s bioavailability and half-life.

    One Molecule, Real-World Impact

    Creating Drostanolone Propionate differs radically from making generic API compounds. Anyone who’s worked with the starting materials — the 2α-methylated DHT backbone and propionic acid — knows the dance of timing, purity, and atmosphere. Down in the wet lab, small changes in temperature or pH translate to real differences in the final product’s purity and crystal form. Our team obsesses over those details because performance depends on more than hitting a purity threshold. We monitor every step, never trusting batch records alone, verifying each fraction through HPLC and GC as well as the more old-fashioned techniques. Only when satisfied do we sign off on a batch—no shortcuts.

    Drostanolone Propionate separates itself from other anabolic substances by its unique balance of anabolic and androgenic activity. Its moderate androgenic strength means fewer troublesome side effects, which can matter greatly in clinical environments and specific research protocols. Compare this to unesterified drostanolone or other esters: The propionate version provides a more predictable dissipation, with the injection frequency matching treatment protocols that minimize accumulation or hormonal imbalances.

    Specifications From the Manufacturer’s Floor

    Working at the origin, we see the specifications not as bullet points to check off, but indicators of every step we’ve taken. Drostanolone Propionate, as we produce it, typically presents as a fine, white crystalline powder. The best batches never carry off-smells, moisture, or contaminants. Achieving consistent quality, with purity above 99%, is harder than most expect. We don't rely on a single method — every shipment receives a full panel of HPLC, GC, MS, and elemental analysis. We’ve seen labs cut corners with fast crystallizations or incomplete solvent recovery. Even slight mishandling at these points creates micro-impurities detectable by the most sensitive analytical instruments. The market sometimes forgets that visually “fine” powders don’t always reveal what’s happening at the molecular level.

    Just so there’s no confusion: our process follows every requirement for Good Manufacturing Practice. We invest in multiple rounds of vacuum drying to guarantee zero residual solvents. Moisture can spark decomposition, and every operator understands that detail. Even packaging, whether it’s glass ampules or vacuum-sealed laminated pouches, takes on a level of care that can only be learned by seeing batches degrade after exposure to air or light. Our QC department regularly outpaces the published monographs in setting tighter specifications, reducing tolerances for impurities, and running additional stability studies that go beyond the norm.

    Practical Applications and Usage

    In legitimate clinical contexts, Drostanolone Propionate earned its place for specific uses, including muscle-wasting conditions and certain cancers. Today, global regulatory shifts have placed tighter controls on its distribution and clinical use, but research continues in a range of settings. We interact with both physicians and lab managers who require not just product, but technical assurances, support with handling and storage, and guidance on safe usage. Users in government-approved research and reference laboratories rely on us because the comfort of clean analytical results stems from promises kept in the manufacturing stage.

    Administration of Drostanolone Propionate usually calls for intramuscular injection due to its moderate ester — designed to provide a steady but temporary curve of activity. The propionate group, with its three-carbon chain, creates a tighter profile, supporting more flexible titration or withdrawal schedules than longer esters like enanthate. For clinical users, this means greater flexibility in regimen adjustment, a huge practical advantage when patient needs change. For research scenarios, the consistent elimination rate allows for simpler analysis and reproducibility. We routinely field questions from pharmaceutical developers refining delivery vehicles, and our technical team shares advice gained from both our own studies and feedback from end-users.

    Comparing to Other Anabolic Compounds

    No two anabolic compounds serve identical roles. Drostanolone Propionate looks similar to other androgens on paper, but there’s a world of difference after synthesis. Compare with testosterone esters: Drostanolone lacks the C-19 methyl group, granting lower aromatization and reducing estrogenic side effects. That means less risk for gynecomastia and fluid retention, two problems often cited in clinical settings. Those working in legitimate sports medicine or forensic labs appreciate the more straightforward metabolite profile, which reduces the likelihood of ambiguous chromatograms during analysis.

    We regularly receive requests for direct comparisons between Drostanolone Propionate and Drostanolone Enanthate. The main difference comes down to the ester chain length. The enanthate ester leads to slower absorption and a longer half-life, often appealing to particular patient or study protocol needs. Meanwhile, the propionate ester delivers a sharper absorption peak and clearance, which some protocols find easier to manage, especially where rapid withdrawal or alteration is required. In practical terms, that means fewer surprises in blood concentrations, easier dose adjustments, and less cumulative burden on the system.

    Classic, unesterified drostanolone fades from the bloodstream much faster, making it less useful in the injection-based protocols used in medicine and research. The propionate version bridges this gap, providing both a steady curve and flexibility for dosing schedules. We’ve supported pharmacologists and clinical trial managers as they calibrated protocols for both safety and efficacy, sharing what our real-world data showed rather than simply repeating literature claims. Sometimes, it comes down to matching the pharmacokinetic profile of our batches to the exact needs of the study or trial, and our direct communication with formulation scientists leads to meaningful results.

    Manufacturing Realities and Challenges

    Making Drostanolone Propionate isn’t a “press a button and walk away” operation. Reactions using 2α-methyl-DHT require sustained inert conditions and temperature control. Oxygen, even in trace amounts, leads to oxidative byproducts that can’t be removed by simple filtration. People new to this chemistry tend to over-filter, assuming activated charcoal removes all colored impurities. In truth, the yellowing sometimes seen comes from deeper issues during synthesis, and only through repeated recystallization and analytical monitoring do we reliably hit pharmaceutical grade.

    Purification brings its own set of headaches. Drostanolone Propionate isn’t as forgiving as some think, tending to incorporate trace solvents if the vacuum work isn’t rigorous enough. Not long ago, we invested in new distillation equipment because our legacy system left parts-per-million levels of isopropanol that caused batch rejections. Fewer companies are willing to eat those costs, but we’ve found the payoff isn’t just in regulatory approval but in winning the trust of researchers and clinicians who probe every sample with modern spectrometry.

    Operators on our floor work closely with QC and analytical teams to track changes down to the microgram per kilogram level. Our best process improvements have always come from collaboration — small process tweaks pioneered by technicians led to reduced impurity formation and increased yield. When a batch underperforms, we trace each parameter, not just blaming raw materials but examining operator technique, atmospheric controls, and previous lot data. It’s not just accountability — it’s respect for science and for the customers depending on us.

    Stability, Storage, and Transport

    Stability studies form the backbone of our post-production process. Drostanolone Propionate, while more stable than the base form, still reacts with moisture and strong light. Actual storage doesn’t just mean “cool, dry place” — we track temperature and humidity from our warehouse to final shipment. We refuse to ship during peak heat, even if it means slower delivery. Glass and high-barrier packaging carry extra costs, but they pay back in product stability. Most customers forget: Drostanolone Propionate loses potency through hydrolysis or photo-oxidation, especially when stored below best-practice standards for extended periods. We’ve seen a 2% assay drop over four weeks in sub-optimal conditions, which for sensitive applications makes all the difference. End users who repackage or subdivide for trials receive not only the product but guidance on reconstitution, aliquoting and minimizing exposure.

    Customs clearance and international transport introduce additional risks—particularly in regions with unpredictable inspections or temperature extremes. Our shipments carry full stability datasheets, and batch-specific handling recommendations are based on genuine transit tests, not marketing or wishful thinking. There’s no sense in cutting corners; the moment of unpacking sets the stage for your downstream work, and our commitment doesn’t stop at our loading dock.

    Regulatory Perspectives

    Staying on the right side of the law means hard work. Drostanolone Propionate presents regulatory complexity, with status varying country by country. We track changing schedules and approval lists with help from legal consultants and in-house compliance personnel, aligning our export policies accordingly. In regulated jurisdictions, our registries and certificates bear the scrutiny of health authorities. For users in research or academic settings, documentation and access processes can shape timelines as much as price or availability.

    We participate in regulatory dialogues that set safety, quality, and traceability benchmarks. Some laws restrict its clinical utility today. We keep rigorous documentation for each API batch, including traceability for each raw material lot. Researchers count on Certificates of Analysis that match not only their protocol needs but also satisfy the most demanding audit requirements. We welcome site inspections, open our records, and have adjusted processes based on both voluntary and required regulatory feedback. Consistent transparency helped us avoid several production holds and regulatory headaches commonly seen in the industry.

    Building on Feedback From Downstream Users

    Feedback from formulation chemists, clinical pharmacologists, and regulatory auditors informs our day-to-day practice as much as raw chemistry does. It isn’t unusual for a technical manager or project leader to contact us directly about a formulation challenge or an unexpected assay drift. We share technical details: the exact gas used for inerting, historical temperature graphs, lot-specific impurity profiles — because that’s where trust is built. Many improvements originated with feedback loops, such as alternate solvent selection or procedural shifts suggested by those handling the compound after it leaves our facility.

    Certain formulation teams require specific particle sizes or micronization techniques due to delivery system demands. We adjust the process in close conversation with these teams, validating the results through real-world testing. By listening to those using Drostanolone Propionate in new excipient combinations or biologics, we sometimes spot issues before they become costly recalls or failed batches. Well-designed products grow from tight, honest partnerships between producer and formulator.

    Looking Toward the Future

    Policies and scientific needs shift. Thanks to continuous dialogue with academic labs, trial sponsors, and global regulators, we anticipate rather than react to new requirements. New analytical technologies help us find impurities that didn’t matter even five years ago. Our investment in process intensification not only conserves resources but improves both safety and output. Environmental regulations in our home country also play a role; solvent recycling and waste minimization are now expectations, not options. Drostanolone Propionate production today includes closed-loop solvent recovery and secondary containment as basic features, not luxuries.

    New applications for Drostanolone Propionate continue to emerge, driven by research not only in classical medicine but in novel receptor studies, tissue engineering, and metabolic investigations. Our technical team tracks and supports these developments. A decade ago, exploratory work in non-traditional anabolic pathways seemed far-fetched; today, such research receives legitimate backing and regulatory clearance. The chemical manufacturer’s job gets more complex as timelines shorten and regulatory burdens tighten, but innovation comes from meeting these challenges head-on.

    Conclusion: Real Value Originates on the Production Floor

    Drostanolone Propionate only becomes a trusted tool when both production experience and integrity line up. Each gram we deliver carries the weight of years spent solving practical problems, facing up to failures, and making improvements for the next batch. End users — from large-scale clinical researchers to method development chemists — share the same ultimate need: accuracy, predictability, and trust in the product that reaches them. Our long-term approach favors investment in both equipment and people, reflecting the knowledge that quality starts long before a Certificate of Analysis ever arrives. This attention to real chemical and operational detail separates reliable Drostanolone Propionate from low-grade substitutes. Our reputation stands on every vial shipped and every question answered — that’s the manufacturer’s perspective, shaped by experience and grounded on substance.